Research progress on the role and mechanism of GDF15 in body weight regulation

被引:8
|
作者
Dong, Xiao-Chen [1 ]
Xu, Dan-Yan [1 ]
机构
[1] Cent South Univ, Dept Internal Cardiovasc Med, Xiangya Hosp 2, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China
关键词
GDF15; weight regulation; obesity; anorexia; insulin resistance; lipid metabolism; DIFFERENTIATION FACTOR 15; GROWTH-FACTOR-BETA; ENERGY-EXPENDITURE; CYTOKINE; RECEPTOR; MICE; PROMOTES; OBESITY; EXPRESSION; PROTECTS;
D O I
10.1159/000535089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Growth differentiation factor-15 (GDF-15) is a member of the growth differentiation factor subfamily in the transforming growth factor beta superfamily. GDF15 has multiple functions and can regulate biological processes. High levels of GDF15 in the circulation can affect metabolic processes. Studies have shown that GDF15 is associated with changes in body weight. Summary: This review reviews the current knowledge on the relationship between GDF15 and body weight change, focusing on the role and mechanism of GDF15 in body weight regulation. GDF15 plays an important role in reducing food intake, improving insulin resistance, and breaking down fat, suggesting that GDF15 has an important regulatory effect on body weight. The mechanism by which GDF15 causes reduced food intake may be related to changes in food preference, delayed gastric emptying, and conditioned taste aversion. GDF15 can combat insulin resistance induced by inflammation or protect beta-cell from apoptosis. GDF15 probably promote lipolysis through a brain-somatic tissue circuit. Several factors and related signaling pathways are also mentioned that can contribute to the effects of GDF15 on reducing weight. Key Message: GDF15 plays an important role in weight regulation and provides a new direction for the treatment of obesity. Its effects on resisting obesity are of great significance to inhibiting the progression of metabolic diseases. It is expected to become a new target for regulating body weight, improving obesity, and treating metabolic diseases such as diabetes.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [31] Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
    Benichou, Olivier
    Coskun, Tamer
    Gonciarz, Malgorzata D.
    Garhyan, Parag
    Adams, Andrew C.
    Du, Yu
    Dunbar, James D.
    Martin, Jennifer A.
    Mather, Kieren J.
    Pickard, Richard T.
    Reynolds, Vincent L.
    Robins, Deborah A.
    Zvada, Simbarashe P.
    Emmerson, Paul J.
    CELL METABOLISM, 2023, 35 (02) : 274 - +
  • [32] Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency
    Finkenstedt, Armin
    Bianchi, Paola
    Theurl, Igor
    Vogel, Wolfgang
    Witcher, Derrick R.
    Wroblewski, Victor J.
    Murphy, Anthony T.
    Zanella, Alberto
    Zoller, Heinz
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (05) : 789 - 793
  • [33] The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21
    Xu, Suowen
    Liu, Zhenghong
    Tian, Tian
    Zhao, Wenqi
    Wang, Zhihua
    Liu, Monan
    Xu, Mengyun
    Zhang, Fanshun
    Zhang, Zhidan
    Chen, Meijie
    Yin, Yanjun
    Su, Meiming
    Fang, Wenxiang
    Pan, Wenhao
    Liu, Shiyong
    Li, Min-dian
    Little, Peter J.
    Kamato, Danielle
    Zhang, Songyang
    Wang, Dongdong
    Offermanns, Stefan
    Speakman, John R.
    Weng, Jianping
    SCIENCE ADVANCES, 2025, 11 (13):
  • [34] Association of GDF15 levels with body mass index and endocrine status in β-thalassaemia
    Karusheva, Yanislava
    Petry, Clive J.
    Yasara, Nirmani
    Kottahachchi, Dulani
    Premawardhena, Anuja
    Barker, Peter
    Burling, Keith
    Sattar, Naveed
    Welsh, Paul
    Mettananda, Sachith
    O'Rahilly, Stephen
    CLINICAL ENDOCRINOLOGY, 2023, 99 (02) : 182 - 189
  • [35] GDF15 Contributes to the Regulation of the Mechanosensitive Responses of PdL Fibroblasts through the Modulation of IL-37
    Steinmetz, Julia
    Stemmler, Albert
    Hennig, Christoph-Ludwig
    Symmank, Judit
    Jacobs, Collin
    DENTISTRY JOURNAL, 2024, 12 (02)
  • [36] GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss
    Borner, Tito
    Wald, Hallie S.
    Ghidewon, Misgana Y.
    Zhang, Bei
    Wu, Zhidan
    De Jonghe, Bart C.
    Breen, Danna
    Grill, Harvey J.
    CELL REPORTS, 2020, 31 (03):
  • [37] The role of syndecans in the regulation of body weight and synaptic plasticity
    Reizes, Ofer
    Benoit, Stephen C.
    Clegg, Deborah J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (01) : 28 - 45
  • [38] Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment
    Diaz, Marta
    Carreras-Badosa, Gemma
    Villarroya, Joan
    Gavalda-Navarro, Aleix
    Bassols, Judit
    de Zegher, Francis
    Lopez-Bermejo, Abel
    Villarroya, Francesc
    Ibanez, Lourdes
    PEDIATRIC RESEARCH, 2023, 93 (04) : 964 - 968
  • [39] Activity-balanced GLP-1/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates
    Zhang, Yuanyuan
    Zhao, Xinyu
    Dong, Xiaona
    Zhang, Yuying
    Zou, Haixia
    Jin, Yaoguang
    Guo, Wei
    Zhai, Peng
    Chen, Xu
    Kharitonenkov, Alexei
    CELL METABOLISM, 2023, 35 (02) : 287 - +
  • [40] GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
    Frikke-Schmidt, Henriette
    Hultman, Karin
    Galaske, Joseph W.
    Jorgensen, Sebastian B.
    Myers, Martin G., Jr.
    Seeley, Randy J.
    MOLECULAR METABOLISM, 2019, 21 : 13 - 21